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Abstract
Objective: To investigate whether asymptomatic middle cerebral artery (MCA) stenosis is associated with risk of
cardiovascular disease (CVD) in Chinese with type 2 diabetes.
Methods: In this prospective cohort study, 2,144 Hong Kong Chinese with type 2 diabetes and without history of stroke or
atrial fibrillation were recruited in 1994–1996 and followed up for a median of 14.51 years. Participants were assessed at
baseline for MCA stenosis using transcranial Doppler. We performed survival analysis to assess the association between
asymptomatic MCA stenosis and first CVD event, defined as ischemic stroke, acute coronary syndrome (ACS) or
cardiovascular death.
Results: Of the 2,144 subjects, MCA stenosis at baseline was detected in 264 (12.3%). Rates of stroke, ACS and cardiovascular
death per 100 were, respectively, 2.24, 2.92 and 1.11 among participants with stenosis, higher than among those without
stenosis. Ten-year cumulative occurrence of stroke, ACS and cardiovascular death in subjects with MCA stenosis was 20%,
24% and 10%, respectively, higher than the corresponding values for subjects without stenosis(all P,0.001). After adjusting
for covariates, MCA stenosis was found to be an independent predictor of stroke [hazard ratio (HR) 1.40, 95%CI 1.05–1.86;
P = 0.02], ACS (HR 1.35, 95%CI 1.04–1.75; P = 0.02) and cardiovascular death(HR 1.56, 95%CI 1.04–2.33; P = 0.03).
Conclusions: Asymptomatic MCA stenosis is a risk factor for CVD in Chinese with type 2 diabetes, and detection of
asymptomatic MCA stenosis by transcranial Doppler can identify diabetic individuals at high risk of future CVD. This finding
is particularly important for diabetic individuals in Asia, where intracranial atherosclerosis is common.
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Introduction
Cardiovascular disease (CVD), including acute coronary syn-
drome (ACS) and ischemic stroke, is responsible for 30% of all
deaths worldwide, most of which occur in developing countries
[1]. Type 2 diabetes shows a strong association with various CVD.
Individuals with type 2 diabetes are at 2- to 4-fold higher risk of
CVD mortality than those without diabetes [2]. In fact, CVD,
particularly coronary artery disease (CAD) resulting from accel-
erated atherosclerosis, is the leading cause of morbidity and
mortality among people with diabetes, causing more deaths than
microvascular complications. In addition, diabetes and ischemic
stroke often occur together [3]. Therefore improving our ability to
identify individuals with diabetes likely to develop CVD may
improve their prognosis.
The strong association between CVD and type 2 diabetes
reflects substantial overlap in their clinical features. Hypertension
and dyslipidemia are well-known risk factors for CVD, and both
frequently occur in diabetes. Atherosclerosis is the leading cause of
CVD, and intracranial atherosclerotic vascular lesions frequently
occur in Chinese with diabetes in the form of middle cerebral
artery (MCA) stenosis [4]. Symptomatic MCA stenosis, as well as
diabetes itself, is significant independent predictors of stroke
recurrence and mortality in Asian patients [5]. MCA stenosis can
PLOS ONE | www.plosone.org 1 September 2014 | Volume 9 | Issue 9 | e106623
also occur in an asymptomatic form that has traditionally been
considered benign [6,7]. Increasing evidence suggests that
asymptomatic MCA stenosis is not benign: it is associated with a
more atherogenic metabolic profile [8] and is an independent
predictor of vascular mortality [9] in Chinese with type 2 diabetes.
These findings suggest that atherosclerotic lesions develop silently
over years until they suddenly become symptomatic. This
highlights the need to detect MCA stenosis early, while it is still
in the asymptomatic phase.
Routine screening for CAD is not recommended for those with
asymptomatic diabetes because it is not thought to improve
outcomes as long as CVD risk factors are treated [10]. This means
that asymptomatic MCA stenosis may go undetected in a
potentially substantial proportion of diabetic population, placing
them at higher risk of CVD in the future. Here we carried out a
prospective cohort study among Hong Kong Chinese with type 2
diabetes to quantify how much asymptomatic MCA stenosis
increases risk of ischemic stroke, ACS and cardiovascular death.
Materials and Methods
The study protocol was approved by the clinical research ethics
committee of the Chinese University of Hong Kong. In this
prospective cohort study, individuals with type 2 diabetes were
recruited from the diabetes clinic at the Prince of Wales Hospital
between 1994 and 1996. All participants were Hong Kong
Chinese who lived in Hong Kong throughout the study period.
Participants gave written, informed consent. None had a history of
stroke, transient ischemic stroke (TIA) or atrial fibrillation.
Baseline Assessment
Patients were considered to have diabetes if the fasting plasma
glucose was $7.8 mmol/l, if 2-h plasma glucose was $
11.1 mmol/l after a 75-g oral glucose tolerance test, or if they
were using antidiabetic medication at the time of enrollment. Type
1 diabetic patients were defined as those having acute symptoms
including heavy ketonuria (over 3+) or ketoacidosis at the original
diagnosis, or as those who required continuous insulin treatment
within 1 year of diagnosis [11]. These individuals made up a small
percentage of those recruited for participation, and they were
excluded from the study.
At baseline, participants were examined by transcranial
Doppler (TCD, EME TC-2000). Two experienced operators
(K.S.W., R.L.) performed all TCD evaluations. We studied the
MCA using a standardized protocol and diagnosed MCA stenosis
when peak systolic flow velocity was $140 cm/s [5]. When
diagnosing stenosis, we also took into account the age of the
patients, the presence of turbulence or musical sound, and whether
the abnormal velocity was segmental. When insonation of the
cerebral arteries was not possible through the temporal window,
the individual was excluded from analyses. These TCD-based
diagnostic criteria have been shown to be as sensitive and specific
as diagnosis based on supplementary magnetic resonance angiog-
raphy (MRA) and clinical outcome [4,12].
Individuals also provided information at baseline about history
of hypertension and ischemic heart disease (IHD), diabetes
duration, smoking, and use of medication, including hypoglyce-
mics (e.g. oral hypoglycemics and insulin), anti-hypertensives,
aspirin and statin. Either current or former smoking was defined as
positive smoking status for the purposes of this study. Peripheral
artery disease (PAD) was diagnosed if claudication, gangrene, or
ischemia-related amputation was present. After overnight fasting,
blood samples were analyzed for fasting blood glucose, hemoglo-
bin A1c (HbA1c), total cholesterol (TC), triglycerides (TG), high-
density lipoprotein cholesterol (HDL-C), and low-density lipopro-
tein cholesterol (LDL-C). Seated blood pressure, body weight,
height and waist circumferences were measured in all participants,
and body mass index (BMI) was calculated. The albumin-to-
creatinine ratio (ACR) in urine was also measured after overnight
fasting. Albuminuria was diagnosed if the ACR was $3.5 mg/
mmol [13]. Retinopathy was assessed by an ophthalmologist at the
time of enrollment. Fundi were examined through dilated pupils,
and retinopathy was considered to be present if one or more of the
following were observed: hemorrhage, microaneurysm, cotton
wool spots, and/or laser coagulation scars related to diabetic
retinopathy.
Outcome Assessment
Participants were followed up from enrollment in 1994–1996
until August 2012. The primary end point was the first
cardiovascular event, defined as ischemic stroke (including TIA)
or ACS. For the purposes of this study, ischemic stroke was defined
as being associated with large-artery atherosclerosis based on the
TOAST classification scheme. ACS was defined as unstable
angina or myocardial infarction with or without ST-segment
elevation. Secondary end points were cardiovascular death due to
stroke or ACS.
Hospitalization and outcomes of study participants were tracked
through the Hong Kong Hospital Authority Central Computer
System, which records admissions to, and discharges from, all
public hospitals in Hong Kong. Participants were unambiguously
identified in this computer system by their unique Hong Kong
Identity Card number, which is compulsory for all residents of
Hong Kong. First ischemic stroke (including TIA) or ACS were
identified based on discharge diagnosis codes 432–436, 410, and
413, according to the International Classification of Diseases,
Ninth Revision (ICD-9). Deaths due to ischemic stroke or ACS
were identified based on ICD-9 discharge codes of 432–438, 410,
or 413. The exact cause of death was determined from death
certificates or medical records. When end points for a given
participant were uncertain, we also reviewed paper-based medical
records or called the patients or their relatives for follow-up.
Statistical Analysis
Values of normally distributed variables, including age, diabetes
duration, and anthropometric and fasting plasma biochemical
parameters, are presented as mean 6 SD. Length of follow-up is
presented as median and interquartile range (IQR). Hemoglobin
A1c (HbA1c) levels are reported both as % and as mmol/mol.
Values of categorical variables, including sex, smoking, hyperten-
sion, PAD, albuminuria, retinopathy, MCA stenosis, IHD history,
and use of medications are presented as percentages.
Baseline characteristics stratified by MCA stenosis were
compared using x2-squared and independent-samples t tests as
appropriate. Whether the presence or absence of asymptomatic
MCA stenosis predicts stroke, ACS and cardiovascular death was
assessed using Kaplan-Meier survival analysis. Cumulative and
mean yearly incidences of ischemic stroke, ACS and cardiovas-
cular death were estimated for individuals with type 2 diabetes
with and without MCA stenosis using life tables. We further
assessed the effect of asymptomatic MCA stenosis on each
outcome by calculating event rates per 100 person-years.
Three Cox proportional hazard regression models were
constructed to identify whether MCA stenosis can predict long-
term clinical outcomes. Results are expressed as hazard ratios
(HRs) with associated 95% confidence intervals (CIs). All models
to assess association between MCA stenosis and cardiovascular
events were adjusted for the following potential confounders: age,
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sex, smoking, hypertension, total cholesterol, LDL, HDL, PAD,
albuminuria, IHD history, diabetes duration, retinopathy, and
HbA1c. In the Cox analyses, HbA1c levels were dichotomized as
,7% or $7% (53 mmol/mol), since this cut-off has been shown
to predict risk of macrovascular disease [14].
All statistical analyses were performed using PASW statistics
(version 18.0, IBM, Chicago, IL, USA). Two-sided p-values of ,
0.05 were considered statistically significant.
Results
During the enrollment period from 1994–1996, 2,585 individ-
uals with diabetes without symptoms of cerebral vascular disease
and atrial fibrillation were recruited. Of these, 44 (1.7%) were
excluded because they had type 1 disease and 344 (13.3%) were
also excluded because insonation of their cerebral arteries through
the temporal window proved impossible. Among the remaining
2,197 individuals with type 2 diabetes, 272 (12.4%) were
diagnosed with MCA stenosis. Since 53 individuals (2.4%) were
lost to follow-up, the final analyses involved 2,144 patients,
corresponding to 97.6% of the original 2,197.
MCA stenosis was diagnosed by TCD in 264 (12.3%). Median
follow-up was 14.51 years (IQR 12.48–15.62; range 0.26–19.49).
Of the 2,144 participants, 353 (16.5%) developed ischemic stroke
and 455 (21.2%) developed ACS. A total of 155 (7.2%) died from
cardiovascular disease.
Baseline clinical characteristics
Table 1 summarizes baseline characteristics of all recruited
individuals, with and without stratification based on MCA
stenosis. Most participants (86.5%) were being treated for
hypoglycemia at the time of enrollment. Individuals with stenosis
were generally older than those without stenosis, and they had had
diabetes longer and their levels of TC and LDL were higher. Prior
macro- and microvascular complications were more frequent
among those with MCA stenosis. Prior or current use of
hypoglycemic or anti-hypertensive medications, aspirin, and statin
was more frequent among those with MCA stenosis.
MCA Stenosis and CVD Incidence
Mean yearly incidences of stroke, ACS and cardiovascular
death in individuals with diabetes and MCA stenosis were,
respectively, 2.06%, 2.67% and 0.944%, which were higher than
the corresponding incidences of 1.42%, 1.67% and 0.47% in those
without stenosis. Individuals with diabetes and MCA stenosis lost
fewer person-years due to stroke, ACS or cardiovascular death.
Rates of stroke, ACS, and cardiovascular death per 100 person-
years were higher among participants with MCA stenosis (2.24,
2.92, 1.11) than among those without it (1.22, 1.66, 0.48)
(Table 2). As described below, significant associations were
observed between the presence of MCA stenosis and the
occurrence of stroke, ACS and cardiovascular death during
follow-up.
Stroke occurred in 64 individuals with MCA stenosis (24.2%,
64/264) and in 289 individuals without stenosis (15.4%, 289/
1880) (P,0.001). Cumulative incidence of stroke at 5, 10, 15 and
18 years was 9%, 20%, 30% and 31% among participants with
MCA stenosis; incidence seemed to plateau near 32%. The
corresponding incidences among individuals without MCA
stenosis were much lower: 5%, 11%, 17% and 24% (log rank
x2 = 21.27, P,0.001; Figure 1).
ACS occurred in 82 individuals with MCA stenosis (31.1%, 82/
264) and in 373 without it (19.8%, 373/1880; P,0.001).
Cumulative incidence of ACS at 5, 10, 15 and 18 years among
those with MCA stenosis was, respectively, 14%, 24%, 35% and
40%; incidence seemed to plateau at 40%. The corresponding
values for those without MCA stenosis were significantly lower:
6%, 13%, 22% and 25% (log rank x2 = 26.87, P,0.001; Figure 2).
Cardiovascular death occurred in 35 cases with MCA stenosis
(13.3%, 35/264) and in 120 cases without stenosis (6.4%, 120/
1880) (P,0.001). Cumulative incidence of cardiovascular death at
5, 10, 15 and 18 years among individuals with MCA stenosis was,
respectively, 3%, 10%, 17% and 19%; incidence seemed to
plateau at 19%. The corresponding values for those without
stenosis were significantly smaller: 1%, 4%, 7% and 9% (log rank
x2 = 22.516, P,0.001; Figure 3).
MCA Stenosis and CVD Risk
Univariate analyses showed that individuals with asymptomatic
MCA stenosis were at higher risk of stroke, ACS and cardiovas-
cular death than were those without MCA stenosis (Table 3,
model 1). Multivariable regression showed that asymptomatic
MCA stenosis was associated with significantly higher risk of stroke
and of ACS, while it was associated with moderately higher risk of
cardiovascular death (HR 1.50, 95%CI 1.00–2.25; P = 0.05)
(Table 3, model 2). These results were obtained after adjusting
for age, sex, smoking, hypertension, total cholesterol, LDL, HDL,
PAD, albuminuria, IHD history, diabetes duration, retinopathy,
and HbA1C. Given recall bias and possible subjectivity in
determining diabetes duration, we repeated the multivariable
analysis after adjusting for the abovementioned factors except for
diabetes duration (Table 3, model 3). The association between
asymptomatic MCA stenosis and elevated risk of stroke and ACS
remained significant. In addition, MCA stenosis was now found to
be associated with significantly higher risk of cardiovascular death
(HR 1.56, 95%CI 1.04–2.33; P = 0.03).
Discussion
In this prospective, long-term cohort study, we evaluated the
association between asymptomatic MCA stenosis and future
cardiovascular events among Chinese with type 2 diabetes. Our
findings indicate that asymptomatic MCA stenosis significantly
increases risk of stroke, ACS and cardiovascular death. This
suggests that detecting MCA stenosis by TCD can help identify
individuals with diabetes at higher risk of these outcomes.
Among Chinese, middle cerebral artery (MCA) stenosis is the
most commonly identified intracranial atherosclerotic vascular
lesion [4]. Intracranial large-artery atherosclerosis (ILAA) is a
major cause of ischemic stroke worldwide [15]; it involves
progressive narrowing of intracranial arteries, leading to arterial
stenosis. Carotid artery atherosclerosis contributes to stroke when
stenosis exceeds 50% [16]. A recent community-based study in
China showed large-artery intracranial occlusive disease to be
more prevalent than carotid artery stenosis [17]. This suggests that
atherosclerosis may begin in intracranial arteries and give rise to
carotid artery stenosis only after progressing and becoming
systemic. The same study also showed no significant association
between the occurrence of intra- and extra-cranial artherosclerosis
[17]. Therefore we focused on MCA stenosis in our participants
and did not collect data on extra-cranial atherosclerosis.
Intracranial large-artery occlusive disease has already been
linked to cardiovascular disease and death. Diabetes conferred a
higher risk for Intracranial atherosclerotic disease than for
extracranial atherosclerotic disease [18]. In a study of Chinese
patients who experienced acute cerebral ischemia, the presence of
occlusive vessels was the strongest predictor of vascular events or
death within 6 months [4]. A study of Chinese with type 2 diabetes
Cardiovascular Disease and Intracranial Atherosclerosis in Diabetics
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Table 1. Baseline characteristics of 2,197 Chinese with type 2 diabetes with and without asymptomatic MCA stenosis.
Characteristic Overall (n = 2197) MCA stenosis (n=272) No MCA stenosis (n =1925) p-value*
Age, years 55.4 (11.3) 59.3 (10.8) 54.8 (11.3) ,0.001{
Male, n(%) 896 (40.8) 102 (37.5) 794 (41.2) 0.24`
BMI, kg/m2 24.9 (3.7) 24.4 (3.6) 24.9 (3.7) 0.03{
Waist circumference, cm 84.6 (9.6) 83.6 (9.7) 84.7 (9.6) 0.11{
Systolic blood pressure, mmHg 138.4 (21.5) 147.4 (23.1) 137.2 (21.0) ,0.001{
Dystolic blood pressure, mmHg 78.9 (11.4) 78.7 (11.9) 78.9 (11.3) 0.82{
Total cholesterol, mmol/l 5.6 (1.1) 5.8 (1.3) 5.6 (1.1) 0.02{
Triglycerides, mmol/l 1.8 (1.6) 1.7 (1.4) 1.8 (1.7) 0.42{
LDL cholesterol, mmol/l 3.6 (0.9) 3.8 (1.1) 3.6 (0.9) 0.003{
HDL cholesterol, mmol/l 1.26 (0.36) 1.27 (0.35) 1.26 (0.36) 0.77{
Fasting glucose, mmol/l 9.06 (3.5) 9.06 (3.3) 9.06 (3.5) 0.99{
HbA1c, % 7.9 (1.9) 7.9 (1.8) 7.8 (1.9) 0.51{
HbA1c, mmol/mol 62.3 (20.3) 63.2 (19.8) 62.1 (20.4) 0.44{
Medical history, n(%)
Smoking 599 (27.3) 80 (29.4) 519 (27.0) 0.40`
Diabetes duration, mo. 81.1 (72.9) 99.8 (79.5) 78.5 (71.5) ,0.001{
Hypertension 1155 (52.6) 195 (71.7) 960 (49.9) ,0.001`
IHD history 62 (2.8) 16 (5.9) 46 (2.4) 0.001`
Albuminuria 659 (30.0) 104 (39.4) 555 (29.7) 0.001`
Peripheral arterial disease 46 (2.1) 14 (5.3) 32 (1.7) ,0.001`
Retinopathy 506 (23.0) 96 (35.3) 410 (21.3) ,0.001`
Medication, n(%)
Hypoglycemic therapy 1901 (86.5) 250 (91.9) 1651 (85.9) 0.007`
Aspirin 32 (1.5) 11 (4.0) 21 (1.1) ,0.001`
Antihypertensive therapy 423 (19.3) 75 (27.6) 348 (18.1) ,0.001`
Statin 112 (5.1) 22 (8.1) 90 (4.7) 0.02`
Data are mean 6 SD or n (%).
BMI, body mass index; ACEI, angiotensin-converting enzyme inhibitors; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MCA,
middle cerebral artery; IHD: ischemic heart disease.
Hypertension was defined as systolic blood pressure $140 mmHg or diastolic blood pressure$90 mmHg, or the use of ACE inhibitors, angiotensin II receptor blockers,
or other antihypertensive drugs.
*P values refer to comparisons between groups with and without MCA stenosis.
{From independent-samples t test.
`From x2-squared test.
doi:10.1371/journal.pone.0106623.t001
Table 2. Rates of stroke, ACS and cardiovascular death among Chinese with type 2 diabetes with or without asymptomatic MCA
stenosis.
No. of events Median (IQR), yr* Person-years Event rate{
Stroke
MCA stenosis 64 12.87 (6.1–14.9) 2857 2.24
No MCA stenosis 289 14.33 (10.6–15.5) 23765 1.22
ACS
MCA stenosis 82 12.60 (5.9–14.9) 2810 2.92
No MCA stenosis 373 14.26 (9.8–15.5) 23377 1.6
Cardiovascular death
MCA stenosis 35 13.91(8.74–15.15) 3158.59 1.11
No MCA stenosis 120 14.61(13.07–15.66) 25192.88 0.48
Abbreviations: ACS, acute coronary syndrome; IQR, interquartile range; MCA, middle cerebral artery.
*Derived from median follow-up period (25th to 75th quartile).
{Derived from event rate per 100 person-years.
doi:10.1371/journal.pone.0106623.t002
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showed asymptomatic MCA stenosis to be an independent
predictor of vascular mortality, including macro- and microvas-
cular events [9]. That study did not, however, examine the
relationship between MCA stenosis and cardiovascular death. The
present work confirms and extends those studies by showing MCA
stenosis to be an independent predictor of cardiovascular death,
Figure 1. Survival plots of examining the association between asymptomatic MCA stenosis and ischemic stroke. Data for type 2
diabetic participants without MCA stenosis are shown with a solid line; data for type 2 diabetic participants with MCA stenosis are shown with a
dashed line. (log rank x2 = 21.27, P,0.001).
doi:10.1371/journal.pone.0106623.g001
Figure 2. Survival plots of examining the association between asymptomatic MCA stenosis and acute coronary syndrome. Data for
type 2 diabetic participants without MCA stenosis are shown with a solid line; data for type 2 diabetic participants with MCA stenosis are shown with
a dashed line. (log rank x2 = 26.87, P,0.001).
doi:10.1371/journal.pone.0106623.g002
Cardiovascular Disease and Intracranial Atherosclerosis in Diabetics
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even after adjusting for a wide range of conventional vascular
disease risk factors.
Studies in Hong Kong Chinese have suggested that atheroscle-
rotic vascular disease may predict ischemic stroke in individuals
with type 2 diabetes [19], and studies in Germany have reported
that a large proportion of the general patient population with
symptomatic MCA stenosis suffer ischemic stroke recurrence [6].
Previous work in Spain reported that stenosis progression
independently predicts stroke recurrence in the general patient
population with symptomatic MCA stenosis [20]. Studies in
Chinese with asymptomatic MCA stenosis indicate that they are at
0.5% risk of ischemic stroke during the first year after stroke onset
and at 1.6% risk during the second year [7]. The present study
confirms and extends this previous work by showing that
asymptomatic MCA stenosis is strongly associated with elevated
risk of ischemic stroke in individuals with type 2 diabetes.
Our finding that Chinese with type 2 diabetes and asymptom-
atic MCA stenosis are at greater risk of ischemic stroke, ACS, and
cardiovascular death runs against the conventional wisdom that
asymptomatic MCA stenosis is benign in Caucasian and Asian
patients [6,7]. Previous studies in Germany and China reported
that plaques in individuals with asymptomatic MCA stenosis were
stable, and that stenosis in those individuals followed a benign
course, leading to low annual incidence of TIA and stroke [6,7]. In
contrast, we found that macrovascular complications (e.g. ischemic
stroke, ACS, and cardiovascular death) and microvascular
complications had occurred in more of our subjects with
asymptomatic MCA stenosis than in those without stenosis. In
addition, the average yearly incidence of stroke in our cohort of
Chinese with diabetes and asymptomatic MCA stenosis was higher
than that reported for a general population of Chinese patients
with asymptomatic MCA stenosis [7]. These findings support the
Figure 3. Survival plots of examining the association between asymptomatic MCA stenosis and cardiovascular death. Data for type 2
diabetic participants without MCA stenosis are shown with a solid line; data for type 2 diabetic participants with MCA stenosis are shown with a
dashed line. (log rank x2 = 22.516, P,0.001).
doi:10.1371/journal.pone.0106623.g003
Table 3. Association between MCA stenosis and risk of cardiovascular events in Chinese with type 2 diabetes.
Event Model 1* Model 2{ Model 3`
HR(95% CI) P value HR(95% CI) P value HR(95% CI) P value
Stroke 1.87(1.43–2.46) ,0.001 1.40 (1.05–1.86) 0.02 1.40 (1.05–1.86) 0.02
ACS 1.86(1.47–2.37) ,0.001 1.34(1.04–1.74) 0.03 1.35(1.04–1.75) 0.02
Cardiovascular death 2.42(1.66–3.52) ,0.001 1.50(1.00–2.25) 0.05 1.56(1.04–2.33) 0.03
Abbreviations: HR, hazard ratio; MCA, middle cerebral artery.
HRs were calculated for participants with MCA stenosis with respect to participants without stenosis.
*Modle 1: Univariable analysis of MCA stenosis using a Cox proportional hazards model.
{Model 2: Cox proportional hazards model adjusted for age, sex, smoking, hypertension, total cholesterol, LDL, HDL, peripheral artery disease, albuminuria, IHD history,
diabetes duration, retinopathy, and HbA1C.
`Model 3: Cox proportional hazards model adjusted for all the above mentioned factors except diabetes duration.
doi:10.1371/journal.pone.0106623.t003
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notion that asymptomatic MCA stenosis can independently
predict the occurrence of cardiovascular events in individuals
with type 2 diabetes.
Inflammatory processes may underlie the observed association
between asymptomatic MCA stenosis and cardiovascular events.
Chronic inflammation plays a significant, independent role in the
onset and development of both atherosclerosis and type 2 diabetes
[21]. Inflammation is known to play a crucial role in all stages of
atherogenesis, from early lesion formation to plaque progression
and destabilization. Indeed, atherosclerosis is considered a
systemic inflammatory disease. C-reactive protein (CRP), a
sensitive indicator of systemic inflammation, has been shown to
be a powerful predictor of future coronary and cerebral ischemic
events, whether first-ever [22,23] or recurrent [24,25]. CRP level
may also predict the progression of atherosclerosis [26]. In fact,
elevated CRP levels within coronary plaques may contribute to the
development and progression of atherosclerosis [27]: instability of
coronary atherosclerotic plaques is the major cause of ACS [28].
If inflammation helps to explain the association between
asymptomatic MCA stenosis and cardiovascular events, then
diabetes is likely to strengthen this link. Individuals with type 2
diabetes exhibit a chronic inflammatory response. These individ-
uals tend to have higher CRP concentrations than those without
diabetes, and elevated CRP in diabetes is associated with increased
risk of non-fatal cardiovascular events and cardiovascular death
[29,30]. Diabetes has been shown not only to enhance athero-
genesis but also to promote vascular inflammation, plaque
instability and clinical sequelae [31]. Therefore we speculate that
diabetes may increase the occurrence of vulnerable plaques and
promote the progression of asymptomatic MCA stenosis and
coronary atherosclerosis, thereby increasing the incidence of
ischemic stroke, ACS and cardiovascular death above the rates
in the absence of diabetes.
Asymptomatic MCA stenosis may not increase the risk of
different cardiovascular outcomes to the same extent. Among
individuals with such stenosis in our cohort, cumulative and
average yearly incidence were higher for ACS than for stroke. We
suggest that atherosclerotic vascular lesions may be more tightly
associated with the development of ACS than of stroke. This
implies that individuals with type 2 diabetes and MCA stenosis are
more vulnerable to ACS than to stroke, which is consistent with
prior reports [32,33].
The principal strengths of this study are that it reports a strong
association between asymptomatic MCA stenosis and cardiovas-
cular events in diabetic individuals based on a large sample size,
long-term follow-up and complementary types of survival analysis.
This is, to our knowledge, the first prospective cohort study on the
impact of asymptomatic MCA stenosis on cardiovascular events.
At the same time, our study has several important limitations.
First, it is a single-center, hospital-based study, so the generaliz-
ability of these findings needs to be validated. Second, although
this study revealed important associations between asymptomatic
MCA stenosis and CVD, it cannot address causation. A large body
of evidence suggests that MCA stenosis is only one element in a
multifactorial pathophysiological process that leads to CVD.
Third, although we adjusted for multiple potential confounders
in our analyses, we cannot exclude residual confounding by
imperfectly measured or unmeasured factors, such as waist hip
ratio or drug use during follow-up. Last but not least, when
evaluating the effects of different treatment on CVD outcomes, we
used the treatments at the baseline and assumed that the patients
kept using the drugs during the whole period since it is difficult to
follow up the changes of medication in such a big group of patients
during a median of 15 years. Considering that there could be some
changes of the treatments during the study period, our present
findings may not accurately evaluate the effects of specific drug.
In conclusion, this study suggests that asymptomatic MCA
stenosis enhances risk for future cerebrovascular and cardiovas-
cular events in Chinese with type 2 diabetes. It also suggests that
asymptomatic MCA stenosis plays a more important role in ACS
than in stroke. One clinical implication of these findings is that
stratifying diabetic patients based on the presence of asymptomatic
MCA stenosis may help guide decisions to initiate primary
prevention measures such as antiplatelet or statin therapy. This
possibility may merit testing in clinical trials.
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